Figure 2. Relationship between age and hazard ratio of RT versus RP for patients with prostate cancer. (A) All groups in SEER. (B) All groups in PLCO. (C) Stage I group in SEER. (D) Stage II group in SEER. (E) Stage III group in SEER. (F) Stage IV group in SEER. SEER, Surveillance, Epidemiology, and End Results; PLCO, the Prostate, Lung, Colorectal, and Ovarian. The solid lines are multivariable adjusted hazard ratios. The shaded areas are the 95% confidence intervals. The dotted lines are coordinate 1 on the vertical axis.